Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1124 | 793 | 87 |
| Full Text Views | 9 | 1 | 0 |
| PDF Downloads | 8 | 1 | 0 |
Biological Screening in the U. S. Army Antimalarial Drug Development Program
Kenneth E. Kinnamon
Kenneth E. Kinnamon
Division of Medicinal Chemistry, Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington, D. C. 20012
Search for other papers by Kenneth E. Kinnamon in
Current site
Google Scholar
PubMed
Search for other papers by Kenneth E. Kinnamon in
Current site
Google Scholar
PubMed
William E. Rothe
William E. Rothe
Division of Medicinal Chemistry, Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington, D. C. 20012
Search for other papers by William E. Rothe in
Current site
Google Scholar
PubMed
Search for other papers by William E. Rothe in
Current site
Google Scholar
PubMed
The methods of testing drugs in the United States Army Antimalarial Drug Development Program are described. To date over two hundred thousand compounds have been screened. For each 3,000 compounds evaluated in the primary screen, only 1 is assessed for efficacy in the final test system. Of those potential antimalarials assessed in this last system, only about half are deemed worthy of preclinical toxicological evaluation.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1124 | 793 | 87 |
| Full Text Views | 9 | 1 | 0 |
| PDF Downloads | 8 | 1 | 0 |